Introduction
Depression is the most common mental health disorder worldwide, 1 and is a leading cause of disability. 2 It is significantly more prevalent among people with cardiovascular disease (CVD) than among the general population, 3 and clinical guidelines recommend depression screening as a component of CVD assessment. 4 Peripheral arterial disease (PAD) is an atherosclerotic disease like coronary artery disease (CAD) and stroke, affecting over 200 million people worldwide. 5 Unlike other CVD, however, PAD comprises a range of progressive vascular syndromes characterized by lower extremity (LE) pain and impaired walking ability, and is a frequent cause of amputations. 6 The burden of depression in CVD and its associated morbidity and mortality are well-established in a large body of research. 7, 8 Nevertheless, the vast majority of published studies either do not include PAD in their estimates, or mention it only in passing. This may in part be due to PAD pathophysiology; approximately 50% of people with PAD report being asymptomatic prior to an acute ischemic event, 9 suggesting that PAD is also widely under-recognized and underdiagnosed. 10, 11 To date, the magnitude of an association between depression and PAD remains unknown.
Aims
We aimed to evaluate the prevalence of depression and depressive-type symptoms in patients with PAD and compare this to the prevalence among patients with CAD. We further sought to assess the evidence for an independent association between depression and clinical outcomes among patients with PAD. Finally, we attempted to identify factors that may influence the PAD-depression association.
Methods

Selection criteria
Studies were considered eligible if they met the following criteria: (a) reported on subjects with PAD or who were followed for incident PAD; (b) utilized a validated assessment tool for depression or depressive-type symptoms; (c) examined the association between PAD and depression. Studies were excluded if they were review articles or case studies.
Search strategy
A medical librarian and a co-investigator designed and implemented literature searches using Medline, PsycINFO, EMBASE, the Cochrane Library, and by screening the citation lists of extracted articles. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocols and guidelines 12 were used to ensure transparent reporting of review methods; Figure 1 presents a flow diagram for the PRISMA process used to identify pertinent studies.
Data extraction and quality assessment
The following information was extracted from each article: study design, country of origin, cohort size, age range, sex distribution, choice of depression assessment tool, and outcome estimates. The Newcastle-Ottawa Scale (NOS) 13, 14 provides a reliable framework for assessing longitudinal and cross-sectional studies, and was used to evaluate methodological quality. For cross-sectional studies, the NOS assesses: (a) the representativeness of the sample; (b) adequacy of the sample size; (c) comparability between respondents and non-respondents; (d) the validity of exposure and outcome measures; (e) the quality of the statistical analysis. The longitudinal version of the scale is similar, but also includes assessments of study duration and losses to follow up. Three reviewers assessed the methodological quality of the studies. Where there was a lack of consensus, the final evaluation was deferred to the content expert for the issue in question (i.e. a psychologist for depression screening tools, a cardiovascular researcher for PAD exposures and outcomes). Lastly, consultation with a statistical expert concluded that the studies were sufficiently heterogeneous in design, implementation and reporting strategies as to make a pooled meta-analysis unlikely to yield valid and generalizable results. Our Flow diagram for identifying studies of depression and/or depressive symptoms among people with peripheral artery disease (PAD). Search terms included: PAD, peripheral artery disease, peripheral arterial disease, peripheral occlusive artery disease, PVD, peripheral vascular disease, IC, intermittent claudication, CLI, critical limb ischemia, depression, mood disorder, depressive mood disorder, depressive mood, affective disorder. approach therefore focused solely on established systematic review methods. Table 1 presents study characteristics of 28 selected publications; 12 cross-sectional [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] and 16 longitudinal. [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] Verification of PAD diagnoses was largely uniform, with authors using investigator-administered ankle-brachial indices (ABIs) or medical chart linkage. Table 2 and Table 3 present the results of the assessments of methodological quality. The majority of the articles met most, if not all the NOS requirements for a methodologically rigorous study 29 and one fell largely short of meeting NOS requirements, indicating it was relatively poorly designed and implemented. 34 Cross-sectional estimates of depression prevalence ranged from 11-48%. In longitudinal studies of subjects who were depressed at baseline, prevalence ranged from 3-36%. As a whole, these rates closely approximate the reported prevalence in CAD patients, which ranges from 20-23%. 43, 44 Associated factors Table 4 outlines outcome estimates of studies that assessed associations with age, sex, race/ethnicity, PAD severity and symptoms, or overall physical function. Most authors concluded that age did not significantly influence the association. Six of 10 studies observed that sex was an effect modifier, and that women were significantly more likely to be depressed than men. 17, 33, 35, 37, 39, 42 Two studies similarly reported that ethnic/racial differences modified the association, 27, 42 and both observed that African American patients were significantly more likely to be depressed than other racial or ethnic groups. Two studies reported opposing conclusions on the impact of ABI on depression and PAD, 26, 41 but three studies observed a significant association between depression and pain at rest 21, 40 or limb edema with freezing sensations. 30 Multiple studies observed that depression was a predictor of slower walking speeds and shorter walking distances.
Results
Characteristics and prevalence
Heterogeneity within depression instruments
Authors utilized 15 different depression assessment tools. The majority of studies (86%) utilized self-report measures of depression as the exclusive criteria for diagnosing depression. This reliance on self-reported depressive symptoms without a clinician's verification accounts for most of the downgrade in the NOS ratings. Of the nine different self-report measures used, six are well-established and regularly used with cardiac populations. 45 The remaining studies 16, 23, 24 used chart review, computer assisted interviews, structured clinical interviews, and combinations thereof. Structured clinical interviews are considered the gold standard in diagnosing depression, 46 and often yield more conservative rates of depression than selfreport instruments in medical populations. 47 
Discussion
In this review, we observed that the prevalence of depression in patients with PAD is similar to the prevalence estimated among CAD patients. This suggests that depression is equally common among various manifestations of CVD. Prevalence estimates for the general population range from 2-10%, 25 and this review confirms that CVD patients in general bear a disproportionate burden of depression.
Depression and disease progression
Unlike other CVD, PAD directly impacts patients' ability to ambulate 48 and is associated with a progressive decline in physical function. 49, 50 Given that depression is an independent predictor of disability and loss of mobility, 51 depressed PAD patients may experience a multifactorial burden of disease that synergistically impacts physical function.
Treatment guidelines for PAD emphasize improving quality of life and decreasing the risk of new CVD events, primarily via pharmacotherapy and revascularization procedures. 52 Revascularization, however, inconsistently improves walking function 53 and patients frequently face a significant risk of post-procedural complications and repeated interventions. 54 Previous cardiac research has reported an association between depression and worse treatment outcomes, observing that depression among CAD patients is correlated with decreased medication adherence, worse surgical outcomes, and poorer overall prognosis compared to non-depressed patients. 7, 55 The publications included in this review report similar observations, suggesting that untreated depression to some degree mitigates the efficacy of established clinical therapies.
Established interventions such as smoking cessation and physical activity are demonstrably effective in improving physical function and reducing the risk of subsequent CVD events, 56, 57 but their effectiveness is frequently limited. 58 Depressed patients are also significantly less likely to engage in regular exercise, 59 as well as less likely to adhere to physical activity recommendations given by their care providers. 60 In this review, only one article reported on physical activity, 22 and observed that depressed patients were less likely to engage in regular exercise than the non-depressed. Unrecognized and untreated depression may significantly diminish the effectiveness of behavioral and lifestyle interventions, nevertheless, given that these types of interventions were largely unexamined in the articles in this review, this remains an area of research that needs further exploration.
Associated factors
This review identified several factors associated with PAD and depression, namely sex, age, race/ethnicity, disease severity and physical function. PAD is equally common among men and women, 61 but traditional risk factors for CVD are less prevalent among women. 62 Women in general are at a greater risk of depression than men, 63 further underscoring that women with PAD are likely all the more vulnerable to depression. Future intervention studies should explore this dynamic further, and investigate whether mental health-focused interventions tailored to women would improve PAD-related outcomes. We also noted disparate outcomes regarding age. There is evidence to suggest that depression in elderly populations may be subclinical by diagnostic standards, yet still etiologically influential, 64 or can manifest as atypical symptoms, such as unintentional weight loss and constipation. 65 Screening tools that assess more typical symptoms may not be sensitive to these manifestations of depression, thereby underestimating true depression prevalence. In a clinical setting, care providers should be aware that older patients may not present with typical signs of depression. A special focus on elderly patients with PAD should be the target of future intervention trials, perhaps piloting a modified screening tool.
Previous observations support our assessment of racial/ ethnic differences; African Americans in general are significantly more likely to experience major depression than Caucasians (4% versus 3.1%), and less likely to seek medical treatment than the general population, (7.6% compared to 13.6%). 66 Racial minorities are also more likely to have unrecognized and under-treated PAD. 67 In a clinical setting, particular attention should be paid to minority patients, who may be less likely to verbalize depressivetype thoughts and symptoms.
Lastly, PAD severity and symptoms may also influence the depression-PAD association. We observed conflicting results in this review, with some studies reporting a significant correlation between depression and limb symptoms 21, 30, 33, 40 or walking ability 22, 43, 46 and others 27, 41 reporting that adjusting for these variables attenuated the association. Although these results do not clarify precisely where PAD severity and symptoms may fall on the causal pathway, they nevertheless underscore the importance of concurrently screening for and addressing depression in PAD patients with diminished physical function.
Future directions in clinical care
To date, one trial by Garnefski et al. 68 has reported conducting a small (n=13) intervention in PAD patients, in which participants completed a self-guided four-week program of cognitive-behavioral therapy (CBT). After completion and subsequent follow up, participants reported significant improvement in depressive symptoms. Promising intervention results notwithstanding, there is a paucity of research into depression interventions for PAD patients. The publications included in this review suggest that depression is a multidimensional problem with various influencing factors and a host of potential outcomes. PAD patients' main points of contact are, and will continue to be vascular care teams. In such settings, assessing depressive symptoms is the crucial first step in referring patients for more comprehensive mental health assessment and treatment. Table 3 . Assessment of longitudinal studies using the Newcastle-Ottawa Scale for evaluating methodological quality.
Study
Selection of the exposed cohort Selection of the non-exposed cohort 
Selection of the exposed cohort: checked if the exposed cohort is truly or somewhat representative of the average community member or peripheral artery disease patient; not checked (grayed out) if the exposed cohort is selected from a convenience sample or if there is no description of the derivation of the cohort. Selection of the non-exposed cohort: checked if the non-exposed cohort is drawn from the same community as the exposed cohort; not checked (grayed out) if drawn from a different source or if there is no description of the derivation of the non-exposed cohort. Ascertainment of exposure: checked if the exposure is ascertained via secure records (such as a surgical record) or via a structured interview; not checked (grayed out) if the exposure is ascertained via a written self-report of if there is no description of how the exposure was ascertained. Outcome not present at baseline: checked if it demonstrated that the outcome of interest was not present at the start of the study; not checked (grayed out) if this was not demonstrated, or if it is unclear whether the outcome of interest was present at baseline. Comparability of cohorts: checked if the cohorts did not significantly differ by design or analysis and the study controlled for the primary variables of interest; not checked (grayed out) if the cohorts differed significantly by design, analysis, did not control for primary variables, or did not include a description of the comparability of cohorts. We propose employing an interdisciplinary care model that integrates vascular medicine and mental health care. Previous trials have demonstrated significant improvements in both depressive symptoms and vascular treatment outcomes among CAD patients who receive care under this model. 69, 70 Generally, integrating mental health specialists in cardiac care has been shown to improve patients' psychosocial functioning 71 and reduce mortality and cardiac event recurrence. 72 A PAD diagnosis can have a significant bearing on a patient's perception of volitional control and self-efficacy regardless of depression. 73, 74 Intervening at, or near the time of diagnosis will allow patients to feel better-equipped when undergoing PAD treatments, as well as potentially more receptive to making critical lifestyle and behavioral changes.
Limitations
Several limitations may impact the generalizability of our findings. Except for one, 28 all the studies examined only symptomatic PAD. Disease severity defined as ABI or degree of stenosis does not always correlate with symptoms. 48 Mortality rates are largely equal between symptomatic and asymptomatic PAD patients, 75 and it may be that people with symptomatic but undiagnosed PAD experience a similar or greater burden of depression compared to the diagnosed. Second, depression is a common comorbidity with other mental health disorders, and may not be an independent predictor of CVD-related outcomes. Given that conditions such as anxiety and panic disorder are also potentially associated with CVD, 76 more comprehensive assessments of mental health may better delineate potential associations with PAD. Next, military service is a potentially mediating factor in the association between depression and outcomes, but the studies in this review did not address this aspect. There is evidence that depression is more prevalent among Veterans than in the general population, 77 and adjusting for this characteristic may have provided more clarification for this dynamic. Finally, the studies relied heavily on self-reported measures of depression, which are not in and of themselves diagnostic. The wide range of prevalence rates found in the results may be attributed to measuring this construct with different instruments and using different criteria to establish a diagnosis of depression. Nevertheless, given the largely rigorous methodological quality of the studies included in this review, there remains a preponderance of evidence that depression comprises a significant burden on the PAD population. The noted limitations do not negate the need to address this critical issue in both intervention trials and clinical care.
Conclusion
This systematic review assessed the available evidence for an independent association between PAD and depression. The prevalence of depression among PAD patients is comparable to that found in the CAD population, and it remains a persistent concern. Depression in PAD is associated with poorer health outcomes, and contributes to an already substantial health burden. Patients with specific demographic and physical characteristics, including female sex, minority race/ethnicity, increased atherosclerotic severity and diminished walking function may be at particularly increased risk for depression. An interdisciplinary care model in which vascular nursing staff and mental health care providers combine their expertise has the potential to identify and intervene in depression before its influence exacerbates PAD-related outcomes.
Implications for practice
• • Vascular care providers are uniquely positioned to observe and assess depressive symptoms in patients with peripheral arterial disease. • • Particular attention should be paid to women, the elderly, and racial/ethnic minorities, who appear to be at increased risk of depression. • • An interdisciplinary care model that combines vascular and mental health care should be employed among depressed patients with peripheral arterial disease, and there is evidence to suggest that such an approach may improve both psychological and cardiovascular outcomes.
